In Brief ACS and MRA award $2.6 million for research focused on reducing immunotherapy side effects – The Cancer Letter Publications
|
In Brief ACS and MRA award $2.6 million for research focused on reducing immunotherapy side effects
The Cancer Letter Publications The American Cancer Society and the Melanoma Research Alliance selected the first group of scientists to receive newly established research grants to investigate how to reduce side effects resulting from cancer treatments with checkpoint inhibitors. |
